Rosenblum Silverman Sutton S F Inc Natera, Inc. Transaction History

Rosenblum Silverman Sutton S F Inc

  • $344 Million
  • Q1 2025

A detailed history of Rosenblum Silverman Sutton S F Inc transactions in Natera, Inc. stock. As of the latest transaction made, Rosenblum Silverman Sutton S F Inc holds 2,000 shares of NTRA stock, worth $320,300. This represents 0.08% of its overall portfolio holdings.

Number of Shares
2,000
Previous 2,000 -0.0%
Holding current value
$320,300
Previous $316,000 10.76%
% of portfolio
0.08%
Previous 0.08%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$85.28 - $112.6 $155,636 - $205,495
-1,825 Reduced 47.71%
2,000 $216,000
Q1 2024

May 14, 2024
BUY
$59.21 - $92.9 $226,478 - $355,342
3,825 New
3,825 $349,000
Q1 2023

May 15, 2023
SELL
$36.57 - $58.29 $43,884 - $69,948
-1,200 Reduced 23.14%
3,985 $221,000
Q3 2022

Nov 15, 2022
SELL
$36.93 - $56.68 $120,465 - $184,890
-3,262 Reduced 38.62%
5,185 $227,000
Q3 2022

Nov 14, 2022
SELL
$36.93 - $56.68 $891,970 - $1.37 Million
-24,153 Reduced 74.09%
8,447 $227,000
Q2 2022

Aug 10, 2022
BUY
$28.13 - $44.54 $34,037 - $53,893
1,210 Added 3.85%
32,600 $1.16 Million
Q1 2022

May 13, 2022
SELL
$30.32 - $91.33 $172,975 - $521,037
-5,705 Reduced 15.38%
31,390 $1.28 Million
Q4 2021

Feb 14, 2022
SELL
$86.26 - $119.0 $1.25 Million - $1.73 Million
-14,545 Reduced 28.17%
37,095 $3.46 Million
Q3 2021

Nov 12, 2021
BUY
$100.17 - $126.36 $1.18 Million - $1.49 Million
11,825 Added 29.7%
51,640 $5.76 Million
Q2 2021

Aug 12, 2021
BUY
$86.05 - $119.72 $3.43 Million - $4.77 Million
39,815 New
39,815 $4.52 Million

Others Institutions Holding NTRA

# of Institutions
651
Shares Held
126M
Call Options Held
975K
Put Options Held
1.09M
View Full List

About Natera, Inc.

NTRA Quotes by TradingView
  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $15.5B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Rosenblum Silverman Sutton S F Inc Portfolio

Follow Rosenblum Silverman Sutton S F Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rosenblum Silverman Sutton S F Inc , based on Form 13F filings with the SEC.

News

Stay updated on Rosenblum Silverman Sutton S F Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email